Trial Profile
The Association Between Exposure to Spironolactone or Amiloride and Fracture Risk Among Subjects Treated With Thiazolidinediones.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Amiloride (Primary) ; Pioglitazone (Primary) ; Rosiglitazone (Primary) ; Spironolactone (Primary) ; Troglitazone (Primary)
- Indications Fracture; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors GSK
- 05 Mar 2010 Planned end date changed from 1 May 2011 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 05 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record